Target intelligence / Profile preview

P-fimbriae of uropathogenic Escherichia coli (Pap)

Target
Pap
Molecular classification
Adhesin, Pilus, Fimbriae, Lectin, Chaperone-usher system protein
01

Overview

P-fimbriae, also known as pyelonephritis-associated pili (Pap), are filamentous surface appendages found on uropathogenic Escherichia coli (UPEC) that play a critical role in the pathogenesis of upper urinary tract infections [Wikipedia]. These structures are assembled via the chaperone-usher pathway and consist of a major pilin rod (PapA) and a distal tip complex containing the PapG adhesin [NIH, 1.3.2]. PapG specifically recognizes and binds to Gal(alpha1-4)Gal-containing glycosphingolipids (globoseries) on the surface of host uroepithelial cells, particularly in the kidneys [NIH, 1.3.1]. This adherence is essential for bacterial colonization, resistance to the flushing action of urine, and the induction of a robust inflammatory response that contributes to tissue damage in pyelonephritis [NIH, 1.3.5]. Therapeutic strategies targeting P-fimbriae include the use of galabiose-based anti-adhesion agents, pilicides that disrupt pilus assembly, and vaccines designed to elicit protective antibodies against the fimbrial subunits [NIH, 1.2.1, 1.2.2].

Other names
Pyelonephritis-associated piliP piliPap fimbriaeGal-Gal fimbriaeP-fimbriae
02

Mechanism of action

Inhibition of bacterial adhesion to host uroepithelial cells by competitive binding to Gal(alpha1-4)Gal receptors and disruption of the chaperone-usher assembly pathway for pilus formation [NIH, 1.2.1, 1.2.2].

03

Biological functions

Bacterial adhesionHost cell colonizationBiofilm formationImmune evasionInflammatory response induction
04

Disease associations

Urinary tract infectionPyelonephritisCystitisUrosepsis
05

Safety considerations

Potential disruption of commensal E. coli populationsDevelopment of bacterial resistance to anti-adhesion agentsCross-reactivity of antibodies with host tissues
06

Interacting drugs

Galabiose analogs

3 more in the full profile.

07

Biomarkers

papG genotypePapG protein expressionGal(alpha1-4)Gal receptor densityAnti-PapG antibody titers

Beyond the preview

Go deeper on P-fimbriae of uropathogenic Escherichia coli (Pap).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P-fimbriae of uropathogenic Escherichia coli (Pap).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call